ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

10.81
Delayed Data
As of Apr 24
 -0.395 / -3.53%
Today’s Change
2.31
Today|||52-Week Range
14.40
+113.21%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for ZIOPHARM Oncology Inc have a median target of 15.00, with a high estimate of 21.00 and a low estimate of 14.00. The median estimate represents a +38.76% increase from the last price of 10.81.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in ZIOPHARM Oncology Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.13
Sales
$200.0K
Reporting Date
May 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -38.89%
 
 
 
 
 
 
Growthannually -70.16%
 
 
 
 
 
 

Sales

Growthquarterly -41.18%
 
 
 
 
 
 
Growthannually -61.16%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account